WillisH.NavarroMD(He/Him)
Hematology • Minneapolis, MNHematologic Oncology
VP, Head of Clinical Development and Pharmacovigilance Aadi Bioscience, Inc.
Dr. Navarro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
909 Fulton Ave SE
2nd Floor
Minneapolis, MN 55455Phone+1 612-676-4200- Is this information wrong?
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 1995 - 1998
Yale-New Haven Medical CenterResidency, Internal Medicine, 1990 - 1993- University of California San Francisco School of MedicineClass of 1990
Certifications & Licensure
AZ State Medical License 2023 - 2025
CA State Medical License 1995 - 2024
MN State Medical License 2019 - 2024- American Board of Internal Medicine Hematology
Clinical Trials
- Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer Start of enrollment: 1999 Jan 01
- Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab Start of enrollment: 2017 Dec 29
- Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy Start of enrollment: 2017 Dec 29
Publications & Presentations
PubMed
- 1 citationsImmune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 TrialPolina Shindiapina, Maciej Pietrzak, Michal Seweryn, Eric McLaughlin, Xiaoli Zhang, Mat Makowski, Elshafa H. Ahmed, Sarah Schlotter, Rebecca Pearson, Rhonda Kitzler, A...> ;Frontiers in Immunology. 2021 Sep 3
- 20 citationsAllogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial.Richard F. Ambinder, Juan Wu, Brent R. Logan, Christine M. Durand, Ryan K. Shields, Uday R. Popat, Richard F. Little, Deborah McMahon, Joshua C. Cyktor, John W. Mellor...> ;Biology of Blood and Marrow Transplantation. 2019 Nov 1
- 9 citationsRisks and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Patients with HIV Infection.Shukaib Arslan, Mark R. Litzow, Nathan W. Cummins, Stacey A. Rizza, Andrew D. Badley, Willis H. Navarro, Shahrukh K. Hashmi> ;Biology of Blood and Marrow Transplantation. 2019 Aug 1
- Join now to see all
Abstracts/Posters
- Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803...Willis H. Navarro, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Long-Term Outcomes of Subjects with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disorder (EBV+PTLD) Following Solid Organ (SOT) or Allogeneic Hematop...Willis Navarro, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Hospital Affiliations
M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
